LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 48.36 | 17.25 | 74 | 4390 | 0.0169 | 0.1999 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 48.36 | 17.25 | 4258 | 4390 | 0.9699 | 0.9924 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 48.36 | 17.25 | 27 | 4390 | 0.0061 | 0.0577 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 48.36 | 17.25 | 4597 | 4390 | 1.0471 | 1.0115 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 50.33 | 17.25 | 86 | 4651 | 0.0185 | 0.2201 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 50.33 | 17.25 | 4557 | 4651 | 0.9798 | 0.9949 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 50.33 | 17.25 | 20 | 4651 | 0.0043 | 0.0185 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 50.33 | 17.25 | 4891 | 4651 | 1.0516 | 1.0125 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 52.30 | 17.25 | 88 | 4798 | 0.0183 | 0.2222 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 52.30 | 17.25 | 4765 | 4798 | 0.9930 | 0.9983 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 52.30 | 17.25 | 18 | 4798 | 0.0038 | 0.0052 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 52.30 | 17.25 | 5144 | 4798 | 1.0720 | 1.0172 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 54.27 | 17.25 | 88 | 4884 | 0.0180 | 0.2215 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 54.27 | 17.25 | 5141 | 4884 | 1.0526 | 1.0126 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 54.27 | 17.25 | 29 | 4884 | 0.0059 | 0.0658 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 54.27 | 17.25 | 5381 | 4884 | 1.1017 | 1.0239 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 56.24 | 17.25 | 103 | 4929 | 0.0209 | 0.2449 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 56.24 | 17.25 | 5524 | 4929 | 1.1207 | 1.0281 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 56.24 | 17.25 | 23 | 4929 | 0.0047 | 0.0359 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 56.24 | 17.25 | 5741 | 4929 | 1.1647 | 1.0377 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.21 | 17.25 | 103 | 4942 | 0.0208 | 0.2447 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.21 | 17.25 | 5903 | 4942 | 1.1944 | 1.0440 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.21 | 17.25 | 33 | 4942 | 0.0067 | 0.0827 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 58.21 | 17.25 | 6268 | 4942 | 1.2682 | 1.0591 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 60.18 | 17.25 | 99 | 5031 | 0.0197 | 0.2379 | MN20160310_N02 | E22 |